University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them (Review)

dc.contributor.authorBurton, M.J.
dc.contributor.authorClarkson, Janet E.
dc.contributor.authorGoulao, Beatriz
dc.contributor.authorGlenny, Anne-Marie
dc.contributor.authorMcBain, Andrew J.
dc.contributor.authorSchilder, Anne G.M.
dc.contributor.authorWebster, Katie E.
dc.contributor.authorWorthington, Helen V
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.date.accessioned2021-09-15T23:11:09Z
dc.date.available2021-09-15T23:11:09Z
dc.date.embargoedUntil2021-09-16
dc.date.issued2020-09-16
dc.descriptionA C K N O W L E D G E M E N T S: We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, fortheirinsightful comments, which helped us to improve these reviews. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign-oF editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draK search strategy. Professor Schilder's time for this project was supported by the National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.en
dc.description.statusPeer revieweden
dc.format.extent42
dc.format.extent417144
dc.identifier176455402
dc.identifierd787739a-b952-4c96-95cc-a23eb53d3a3d
dc.identifier85085094740
dc.identifier000579343700008
dc.identifier.citationBurton, M J, Clarkson, J E, Goulao, B, Glenny, A-M, McBain, A J, Schilder, A G M, Webster, K E & Worthington, H V 2020, 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them (Review)', Cochrane Database of Systematic Reviews, vol. 2020, no. 9, CD013627. https://doi.org/10.1002/14651858.CD013627.pub2en
dc.identifier.doi10.1002/14651858.CD013627.pub2
dc.identifier.iss9en
dc.identifier.issn1469-493X
dc.identifier.urihttps://hdl.handle.net/2164/17083
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85085094740&partnerID=8YFLogxKen
dc.language.isoeng
dc.relation.ispartofCochrane Database of Systematic Reviewsen
dc.subjectCORONAVIRUSen
dc.subjectR Medicineen
dc.subjectPharmacology (medical)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRen
dc.titleAntimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them (Review)en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Burton_et_al_2020_CDSR_AntimicrobialMouthwashesAnd_VoR.pdf
Size:
407.37 KB
Format:
Adobe Portable Document Format

Collections